The Monitoring and Evaluation Division coordinates the process of planning and budgeting at the FDA. It is also responsible for monitoring and evaluation of the FDA’s annual programme of work and strategic plan. The Division ensures increased, and continuous improvement in performance of the organisation in executing its mandate as per Parts 6, 7 & 8 of the Public Health Act, 2012, Act 851.
The Mandate of the Monitoring and Evaluation is defined by the following Sections of part 7 of the Public Health Act, 2012; • Section 82 (f) Functions of the Authority
SCOPE OF MANDATE
The Division coordinates the preparation, monitoring and evaluation programme of work, budget and donor-funded projects for FDA.
FUNCTIONS OF THE DIVISION
The Operational activities are as follows:
i. Coordinate the preparation of the annual programme of work
ii. Coordinate preparation of annual budget
iii. Monitoring implementation of the annual programme of work
iv. Monitoring implementation of the annual budget
v. Evaluation of programme of work implementation performance
vi. Monitoring visits for data verification
vii. Management of M&E data centre
viii. Prepare institutional presentations
ix. Representation of the FDA at relevant meetings at MOH
• Representation at the Heads of Agencies and Partners Meeting
• Representation at the quarterly budget committee meeting
• Representation at the annual budget technical hearing meeting
• Participation in budget projection workshops (compensation, revenue and expenditure).
• Representation at the MOH POW preparatory meeting
The Division executes its mandate with the following operational units: monitoring and evaluation, budget and planning.
The FDA exists to protect public health by assuring the safety, efficacy and security of human and veterinary drugs, food, biological products, cosmetics, medical devices, household chemical substances, tobacco and the conduct of clinical trials in the country.